Point72 Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.5M | Buy |
|
|||||
|
2025
Q1 | $26.1M | Sell |
|
|||||
|
2024
Q4 | $143M | Buy |
|
|||||
|
2024
Q3 | $118M | Sell |
|
|||||
|
2024
Q2 | $125M | Sell |
|
|||||
|
2024
Q1 | $232M | Buy |
|
|||||
|
2023
Q4 | $122M | Sell |
|
|||||
|
2023
Q3 | $126M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $3.64M | Sell |
|
|||||
|
2022
Q4 | $24.9M | Buy |
|
|||||
|
2022
Q3 | $25.7M | Sell |
|
|||||
|
2022
Q2 | $24.9M | Buy |
|
|||||
|
2022
Q1 | $26.5M | Buy |
|
|||||
|
2021
Q4 | $31.4M | Buy |
|
|||||
|
2021
Q3 | $9.47M | Sell |
|
|||||
|
2021
Q2 | $13.3M | Sell |
|
|||||
|
2021
Q1 | $19.5M | Buy |
|
|||||
|
2020
Q4 | $17.3M | Buy |
|
|||||
|
2020
Q3 | $8.02M | Buy |
|
|||||
|
2020
Q2 | $6.92M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $850K | Sell |
|
|||||
|
2019
Q3 | $1.99M | Buy |
|